Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025:2968:281-289.
doi: 10.1007/978-1-0716-4750-9_16.

Artificial Intelligence and Chromothripsis

Affiliations
Review

Artificial Intelligence and Chromothripsis

Davide Callegarin et al. Methods Mol Biol. 2025.

Abstract

Artificial intelligence (AI) emerges as a new alternative in the healthcare domain, particularly in genomics, promising to revolutionize medicine with its various applications. In this chapter, we explore the potential of AI in genetics and research, with a particular focus on its role in the detection and characterization of chromothripsis. Chromothripsis, marked by complex genomic rearrangements, presents significant challenges in detection and interpretation. Traditional methods such as karyotyping, FISH, array-CGH, and NGS have limitations in accurately identifying chromothripsis events. However, recent advances in AI, including deep learning and machine learning, offer promising opportunities to overcome these challenges. By utilizing machine learning and deep learning algorithms, researchers can analyze complex genomic datasets, identify recurrent patterns, and predict functional consequences associated with chromothripsis with unprecedented accuracy. Additionally, AI facilitates the integration of multi-omics data, enabling a holistic understanding of chromothripsis in various pathological contexts. Through case studies and recent advancements, we highlight the potential of AI in advancing our understanding of chromothripsis and its clinical applications.

Keywords: Artificial intelligence; Chromothripsis; Whole genome sequencing.

PubMed Disclaimer

References

    1. Wojtara M, Rana E, Rahman T et al (2023) Artificial intelligence in rare disease diagnosis and treatment. Clin Transl Sci 16:2106–2111 - PubMed - PMC
    1. Farina E, Nabhen JJ, Dacoregio MI et al (2022) An overview of artificial intelligence in oncology. Future Sci OA 8(4):FSO787. https://doi.org/10.2144/fsoa-2021-0074 - DOI - PubMed - PMC
    1. Dlamini Z, Francies FZ, Hull R et al (2020) Artificial intelligence (AI) and big data in cancer and precision oncology. Comput Struct Biotechnol J 18:2300–2311 - PubMed - PMC
    1. Dias R, Torkamani A (2019) Artificial intelligence in clinical and genomic diagnostics. Genome Med 19:70
    1. Koltsova AS, Pendina AA, Efimova OA et al (2019) On the complexity of mechanisms and consequences of chromothripsis: an update. Front Genet 10:393. https://doi.org/10.3389/fgene.2019.00393 - DOI - PubMed - PMC

LinkOut - more resources